display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced OC (mOC) - maintenance (M)
metastatic/advanced OC (mOC) - maintenance (M)
poly ADP-ribose polymerase (PARP) inhibitor
rucaparib ATHENA-COMBO ...

Study type: